Showing results (171-180 of 1,007) with videos related to
Sort By:
Pageof 101
Parkinson'S Disease|July 4, 2012
A(2A) Receptor Antagonism and Dyskinesia in Parkinson's DiseaseMicaela Morelli, Fabio Blandini, Nicola Simola, et al.Planta|January 11, 2014
The APX4 locus regulates seed vigor and seedling growth in Arabidopsis thalianaYa-Ying Wang, Amanda G Hecker, Bernard A HauserJournal of Parkinson'S Disease|June 23, 2020
Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome DyskinesiaRobert A Hauser, Leonid Zeitlin, Stanley Fisher, et al.Marine Pollution Bulletin|February 27, 2019
Inihibition of mullet (M. liza) brain acetylcholinesterase activity by in vitro polycyclic aromatic hydrocarbon exposureR A Hauser-Davis, R M Lopes, R L ZiolliExpert Review of Neurotherapeutics|January 28, 2021
Istradefylline - a first generation adenosine A2A antagonist for the treatment of Parkinson's diseasePeter Jenner, Akihisa Mori, Stephen D Aradi, et al.Mayo Clinic Proceedings|January 13, 2001
Treatment of nonfebrile status epilepticus in Rochester, Minn, from 1965 through 1984G D Cascino, D Hesdorffer, G Logroscino, et al.Neurology|June 1, 1984
Seizures and head injury in an urban communityW A Hauser, K Tabaddor, P R Factor, et al.The American Journal of Pathology|July 1, 1993
Fibronectin expression correlates with U937 cell adhesion to migrating bovine aortic endothelial cells in vitroI A Hauser, E Setter, L Bell, et al.The Journal of Infectious Diseases|September 1, 1986
Epidemiology of central nervous system infections in Olmsted County, Minnesota, 1950-1981A Nicolosi, W A Hauser, E Beghi, et al.Movement Disorders Clinical Practice|January 15, 2019
Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson DiseaseRobert A Hauser, Italo Biaggioni, L Arthur Hewitt, et al.Pageof 101